Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01383174 · ClinicalTrials.gov registry record · NA
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas
A NA study of Breast Neoplasms and Psychology, Social, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
- 1
- Study location
NCT01383174: Completed NA study of Breast Neoplasms and Psychology, Social, sponsored by University of California, San Francisco.
NCT01383174 is a NA study of Breast Neoplasms and Psychology, Social that has completed, run by University of California, San Francisco. The registered enrollment target is 151 participants, below the 567-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01383174, a NA study of Breast Neoplasms and Psychology, Social, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test whether a new program Nuevo Amanecer (A New Dawn), improves the quality of life of Latinas diagnosed with breast cancer. Trained Latina counselors who have had breast cancer provide support to recently diagnosed women. The investigators call these counselors peer support counselors.
Primary Outcome
FACT-B was used as the breast cancer-specific quality-of-life measure. FACT-B consists of 5 subscale scores pertaining to 4 well-being dimensions (physical, social-family, emotional, functional) and additional breast cancer concerns. A total overall score is the sum of all subscales. Response options were 0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, and 4=very much. Psychometric analysis in our Spanish-speaking Latina sample resulted in modifications to FACT-B: physical well-being s
Conditions Studied
Interventions
- BEHAVIORAL Peer Support Program
Study Locations (1)
California
- - Multiple Locations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2011-02 |
| Est. Completion | 2014-05 |
| Phase | NA |
What the finished NCT01383174 record still lists
NCT01383174 is an interventional study that assigns participants to a tested intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap, below the 567-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with Breast Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Peer Support Program is the first listed.
NCT01383174 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01383174 about?
NCT01383174 is a clinical study titled "Nuevo Amanecer: Promoting the Psychosocial Health of Latinas". The purpose of this study is to test whether a new program Nuevo Amanecer (A New Dawn), improves the quality of life of Latinas diagnosed with breast cancer. Trained Latina counselors who have had breast cancer provide support to recently diagnosed women. The investigators call these counselors peer...
What is the current status of trial NCT01383174?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2011-02. Estimated completion is 2014-05.
What conditions does trial NCT01383174 study?
This clinical trial studies the following conditions: Breast Neoplasms, Psychology, Social.
What interventions are being tested in trial NCT01383174?
The interventions under investigation include: Peer Support Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01383174?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01383174 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01383174's enrollment target sits among peer trials
151 46th of 97 higher than 52 of 97 other Breast Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Breast Cancer, Reasoning, and Activity Intervention
RECRUITING · NA
-
Biennial CEM in Women With a Personal History of Breast Cancer
RECRUITING · NA
-
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
RECRUITING · NA
-
Dissemination of BREASTChoice AIM1-B
RECRUITING · NA
-
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
ACTIVE NOT RECRUITING · NA
-
Lifestyle, Exercise, and Nutrition Study Early After Diagnosis
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia